Accelerating Precision Medicine

Multi-gene testing is an essential part of the patient pathology workup for a growing list of clinical decisions. But implementing sequencer-based testing is a challenge for many laboratories. Managing large data files requires new IT infrastructure and computational power. Analytics must be built and tuned for each instrument and reagent, requiring costly validation.

Realizing the true potential of precision medicine requires clinical-grade analytics and data management. A solution that is system and reagent agnostic, and can support you as your sequencing-based testing program expands.

Farsight Genome Systems is making the promise of precision medicine a reality.

Clinical-Grade Genomic Data Management & Analytics

Farsight Genome Systems is unlocking genomic-centered medicine for clinicians. Farsight Correo is our clinical-grade, cloud-based data management and analytics platform, enabling pathology laboratories to routinely deliver sequencing-based testing. The system is easy to implement, compatible with today’s top sequencing instruments and optimized for clinical laboratories that need easy-to-validate, sequencing-based test panels that can expand with clinical science advancements.

Built for the Pathology Laboratory

Physicians rely on your team for accurate and reliable diagnoses to guide patient care. A growing list of clinical decisions require multi-gene testing to select treatment based upon the patient’s genome – precision medicine. Farsight Correo can accelerate your precision medicine programs.

Currently running sequence-based testing in your laboratory but need to add new tests faster? If your LIS has added Powered by Farsight, you can bring up your next multi-gene test with a phone call.

Looking to start performing sequence-based testing in your laboratory? Contact your LIS vendor and ask if they have added Powered by Farsight. If so, you can be quickly up and running using a gene list of your own, or one of the 15 Premium Testpanels Farsight is co-developing with leading content providers.

What are you waiting for? With Farsight Correo you finally have a clinical-grade alternative to ramp up your sequencing-based testing program.

%

New Drug Development Programs with molecular targets

CAP Accredited laboratories in the US

Accredited laboratories performing NGS

Patients eligible for multi-gene testing (per year)

Why Farsight Correo?

N

Easy to implement

Cloud-based, API-enabled and embedded in a growing list of Laboratory Information Systems

f

Expandable

Easily add a new NGS test, or upgrade an existing one



Proven performance

3000+ patient samples run to date and growing

~

Clinical-grade

Built for CLIA compliance, with sample-level traceability and controls

Genomic medicine beyond oncology

“Oncology is on fire with [personalized medicine], with treatment selections based on individual molecular characteristics. This is also happening with chronic infectious diseases, and genetic diseases are not far behind.”

– Janet Woodcock, Director Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Personalized medicine at the center

“Personalized medicine stands right at the center of [the health care] revolution, with the science enabling greater precision that not only can improve the lives of patients, but can also create efficiencies within the
health care system by delivering the right treatment to the right patient at the right time.”

– Stephen J. Ubl, President and CEO, PhRMA

Request more information

To learn more about Farsight Genome Systems, complete the form and a company representative will follow up with you directly.